Polycystic ovarian disease (PCOD)—pregnancy rate and outcome in in vitro fertilization

[1]  J. Dor,et al.  The effect of gonadotropin-releasing hormone agonist on the ovarian response and in vitro fertilization results in polycystic ovarian syndrome: a prospective study. , 1992, Fertility and sterility.

[2]  T. Tanbo,et al.  In-vitro fertilization in infertile women with the polycystic ovarian syndrome. , 1991, Human reproduction.

[3]  T. Tanbo,et al.  Stimulation with human menopausal gonadotropin versus follicle‐stimulating hormone after pituitary suppression in polycystic ovarian syndrome , 1991, Fertility and sterility.

[4]  E. Rudak,et al.  The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: a comparison of results with those of patients with tubal infertility. , 1990, Human reproduction.

[5]  R. Jewelewicz,et al.  Alternate regimens for ovulation induction in polycystic ovarian disease. , 1990, Fertility and sterility.

[6]  T. Tanbo,et al.  Stimulation with human menopausal gonadotropin versus follicle-stimulating hormone after pituitary suppression in polycystic ovarian syndrome. , 1990 .

[7]  D. Ayalon,et al.  IVF-ET in women with refractory polycystic ovarian disease. , 1989, European journal of obstetrics, gynecology, and reproductive biology.

[8]  J. Antoine,et al.  Comparison between long and short protocols of LHRH agonist in the treatment of polycystic ovary disease by in-vitro fertilization. , 1988, Human reproduction.

[9]  J. Antoine,et al.  Results of IVF in the treatment of polycystic ovary disease. , 1988, Human reproduction.

[10]  W. Dmowski,et al.  Successful use of gonadotropin-releasing hormone agonist leuprolide for in vitro fertilization in a patient with polycystic ovarian disease and infertility unresponsive to standard treatment. , 1988, Fertility and sterility.

[11]  R. Edwards,et al.  EFFECT OF HIGH TONIC LEVELS OF LUTEINISING HORMONE ON OUTCOME OF IN-VITRO FERTILISATION , 1986, The Lancet.

[12]  G. Mccune,et al.  Successful treatment of infertile women with oligomenorrhoea using a combination of an LHRH agonist and exogenous gonadotrophins , 1985, British journal of obstetrics and gynaecology.

[13]  R. García-Flores,et al.  Progressive dosages of clomiphene in hypothalamic anovulation. , 1984, Fertility and sterility.

[14]  J. Halme,et al.  Factors Affecting the Pregnancy Rate in Clomiphene Citrate Induction of Ovulation , 1983, Obstetrics and gynecology.

[15]  V. Davajan,et al.  An extended regimen of clomiphene citrate in women unresponsive to standard therapy. , 1982, Fertility and sterility.

[16]  D. Mishell,et al.  Clinical and laboratory predictors of clomiphene response. , 1982, Fertility and sterility.

[17]  M. Shepard,et al.  Relationship of weight to successful induction of ovulation with clomiphene citrate. , 1979, Fertility and sterility.

[18]  M. J. Berger,et al.  Clinical Aspects of the Polycystic Ovary Syndrome , 1977, Obstetrics and gynecology.

[19]  D. Mishell,et al.  An individualized graduated therapeutic regimen for clomiphene citrate. , 1974, American journal of obstetrics and gynecology.

[20]  M. J. Whitelaw,et al.  The significance of the high ovulation rate versus the low pregnancy rate with Clomid. A review of 203 private anovulatory patients. , 1970, American journal of obstetrics and gynecology.